ZA945038B - Image contrast enhancing composition - Google Patents

Image contrast enhancing composition

Info

Publication number
ZA945038B
ZA945038B ZA945038A ZA945038A ZA945038B ZA 945038 B ZA945038 B ZA 945038B ZA 945038 A ZA945038 A ZA 945038A ZA 945038 A ZA945038 A ZA 945038A ZA 945038 B ZA945038 B ZA 945038B
Authority
ZA
South Africa
Prior art keywords
image contrast
enhancing composition
contrast enhancing
human
relates
Prior art date
Application number
ZA945038A
Other languages
English (en)
Inventor
Tore Bach-Gansmo
Anders Ericcson
Anne Kjersti Fahlvik
Anders Hemmingsson
Mats Wikstrom
Audun Oksendal
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of ZA945038B publication Critical patent/ZA945038B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Signal Processing (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Semiconductor Lasers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA945038A 1993-07-12 1994-07-12 Image contrast enhancing composition ZA945038B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314499A GB9314499D0 (en) 1993-07-12 1993-07-12 Method

Publications (1)

Publication Number Publication Date
ZA945038B true ZA945038B (en) 1995-03-27

Family

ID=10738767

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945038A ZA945038B (en) 1993-07-12 1994-07-12 Image contrast enhancing composition

Country Status (14)

Country Link
US (2) US5869023A (xx)
EP (1) EP0708927B1 (xx)
JP (1) JPH09502426A (xx)
CN (1) CN1127040A (xx)
AT (1) ATE166464T1 (xx)
AU (1) AU7129594A (xx)
CA (1) CA2165086A1 (xx)
DE (1) DE69410466T2 (xx)
ES (1) ES2116600T3 (xx)
GB (1) GB9314499D0 (xx)
NO (1) NO960120L (xx)
NZ (1) NZ268397A (xx)
WO (1) WO1995002831A1 (xx)
ZA (1) ZA945038B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
DE19719033C1 (de) * 1997-04-29 1999-01-28 Schering Ag Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
GB9809776D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
SE9803718D0 (sv) 1998-05-26 1998-10-28 Klaus Potthoff Diagnostiseringsmedel
EP1105162A1 (en) * 1998-08-10 2001-06-13 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
CZ2002343A3 (cs) * 1999-07-29 2002-08-14 Epix Medical, Inc. Cílená multimerní zobrazovací činidla s multilokální vazebnou schopností
US6804546B1 (en) * 2001-04-20 2004-10-12 Koninklijke Philips Electronics, N.V. Multiple contrast echo-planar imaging for contrast-enhanced imaging
US6723052B2 (en) * 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
NO20020780D0 (no) * 2002-02-15 2002-02-15 Amersham Health As Bildeanalyse
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
DE602005009173D1 (de) * 2004-05-03 2008-10-02 Koninkl Philips Electronics Nv System und verfahren zur magnetresonanzabbildung
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
US20060020152A1 (en) * 2004-07-22 2006-01-26 Theobald Eugene H Method for the low temperature selective oxidation of hydrogen contained in a hydrocarbon stream
NO20043746L (no) * 2004-09-07 2006-03-08 Heidi Brurok MRI-metode for a vurdere myokardisk funksjon, levedyktighet og perfusjon i ischemisk hjertesykdom
US7854705B2 (en) * 2004-12-16 2010-12-21 Olga Pawluczyk Ex vivo verification of biopsy tissue samples
EP1891455A2 (en) * 2005-06-01 2008-02-27 Philips Intellectual Property & Standards GmbH Determination of distribution information of a contrast agent by mr molecular imaging
JP5242672B2 (ja) * 2007-04-11 2013-07-24 オレゴン ヘルス アンド サイエンス ユニバーシティ 心臓における線維症の非侵襲性の定量的検出のためのシステム
EP2192922A4 (en) 2007-09-17 2010-09-29 Univ California INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGING PROSTATE <I> IN SITU CANCER CELLS </ I>
CN104274840A (zh) * 2007-12-05 2015-01-14 马维尔生物科学公司 纳米级对比剂和使用方法
AU2009257279A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
EP2332122A4 (en) 2008-10-02 2013-11-20 Univ Western Ontario SYSTEM AND METHOD FOR IMAGE PROCESSING
EP2684048B1 (en) 2011-03-11 2018-10-03 Board of Regents of the University of Nebraska Biomarker for coronary artery disease
CA3006759A1 (en) 2015-11-30 2017-06-08 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
US11504546B2 (en) 2019-02-28 2022-11-22 Cowles Ventures, Llc Needle guidance device for brachytherapy and method of use
US11524176B2 (en) 2019-03-14 2022-12-13 Cowles Ventures, Llc Locator for placement of fiducial support device method
MX2023001625A (es) 2020-08-07 2023-05-16 Fortis Therapeutics Inc Inmunoconjugados que se dirigen a cd46 y metodos de uso de los mismos.
US11630219B2 (en) * 2021-07-29 2023-04-18 Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C Pressure-regulating large-area windowless airflow proportional counter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
IT1246380B (it) * 1990-04-12 1994-11-18 Bracco Spa Sali insolubili di lantanidi per la visualizzazione in risonanza magnetica nucleare del tratto gastro-intestinale
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region

Also Published As

Publication number Publication date
ES2116600T3 (es) 1998-07-16
US5869023A (en) 1999-02-09
DE69410466D1 (de) 1998-06-25
NO960120L (no) 1996-03-11
WO1995002831A1 (en) 1995-01-26
CN1127040A (zh) 1996-07-17
ATE166464T1 (de) 1998-06-15
EP0708927A1 (en) 1996-05-01
US6045775A (en) 2000-04-04
NZ268397A (en) 1997-11-24
AU7129594A (en) 1995-02-13
DE69410466T2 (de) 1999-02-18
CA2165086A1 (en) 1995-01-26
EP0708927B1 (en) 1998-05-20
JPH09502426A (ja) 1997-03-11
NO960120D0 (no) 1996-01-11
GB9314499D0 (en) 1993-08-25

Similar Documents

Publication Publication Date Title
ZA945038B (en) Image contrast enhancing composition
HU9303489D0 (en) Water insoluble manganese particles as magnetic resonance contrast enhancement agents
EP0527690A3 (en) Contrast enhancement of electrographic imaging
IL105216A0 (en) Method and kit for the diagnosis of alzheimer&#39;s disease
MY134906A (en) Prevention and treatment of amyloidogenic disease
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer&#39;s disease and composition thereof
AU7043894A (en) Composition and method for (in vivo) imaging of amyloid deposits
ZA864987B (en) Lymphographic imaging reagents and kit
HK18094A (en) Use of ferromagnetic particles in contrast agents for nmr imaging and contrast agents
CA2095832A1 (en) Molecular sieve-enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract
IT1256248B (it) Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
GB2276945A8 (en) MRI magnet with both ferromagnetic and permanent magnet field correction
DE68928610D1 (de) Passiver Ausgleichskörper zur Korrektur von (3,2)- und (3,-2)-harmonischen Gliedern bei magnetischen Resonanzmagneten
CA2142302A1 (en) Method of improving fat saturation during mri
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR FIXING TAU AND MAP2c PROTEINS
AU2172197A (en) Method of T1-weighted magnetic resonance imaging of RES organs
EP0513385A4 (en) Iron-base soft magnetic alloy
NZ231932A (en) Electron spin resonance enhanced magnetic resonance imaging: use of contrast agents
EP0948361A4 (en) MAGNETIC RESONANCE BLOOD POOL IMAGING AGENTS
SG49230A1 (en) Vectors expressing of human interferon for the treatment of AIDS
CA2060536A1 (en) Specific contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
DE9421816U1 (de) In den menschlichen Körper einführbares Instrument
EP0527774A4 (en) Calcitonin gene related peptide for the treatment of undescended testicles
IT1254976B (it) Fattori chemiotattici